Daclizumab/sirolimus/tacrolimus: Myocarditis and cardiomyopathy (first report with sirolimus and daclizumab): 2 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1087, 2006-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Daclizumab/sirolimus/tacrolimus: Eosinophilia in an Islet cell transplant recipient (first report with daclizumab): case report

By  

Reactions Weekly, Vol. 1, Iss. 1056, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Immunosuppressants: Epstein-Barr virus infection (first report for daclizumab) and leiomyosarcomas (first report for daclizumab, mycophenolate mofetil, sirolimus and tacrolimus): case report

By  

Reactions Weekly, Vol. 1, Iss. 1173, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Immunosuppressants: Ovarian and uterine cancer (first report for mycophenolate mofetil, sirolimus and tacrolimus) in renal transplant recipients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Sirolimus interaction: First report of an interaction with voriconazole leading to increased serum sirolimus concentrations: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1046, 2005-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Sirolimus: First report of hyperlipidaemia: 6 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1016, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite